Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “PD-1 Antibodies”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT03139851
What this trial is testing

Evaluation of Pembrolizumab in Lymphopenic Metastatic Breast Cancer Patients Treated With Metronomic Cyclophosphamide

Who this might be right for
Metastatic Breast Cancer
Centre Leon Berard 36
Not applicableUnknownNCT05025592
What this trial is testing

CTACE or DEB-TACE+HAIC Combined With Regorafenib ± Anti-PD1 Antibody for uHCC

Who this might be right for
HCCTransarterial ChemoembolizationHepatic Arterial Infusion Chemotherapy+1 more
Peking University Cancer Hospital & Institute 60
Testing effectiveness (Phase 2)Active Not RecruitingNCT07801352
What this trial is testing

CapeOx Combined With Anti-PD1 Antibody Plus Dihydroartemisinin as Neoadjuvant or Conversion Therapy for Microsatellite Stable Locally Advanced and Metastatic Colorectal Cancer

Who this might be right for
Locally Advanced Colorectal CancerMetastatic Colorectal Cancer
Shanghai Changzheng Hospital 15
Testing effectiveness (Phase 2)Looking for participantsNCT06437522
What this trial is testing

BL-B01D1+PD-1 Monoclonal Antibody in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma and Other Solid Tumors

Who this might be right for
Head and Neck Squamous Cell Carcinoma
Sichuan Baili Pharmaceutical Co., Ltd. 46
Early research (Phase 1)Study completedNCT05242445
What this trial is testing

Cetrelimab in Participants With Chronic Hepatitis B Virus Infection

Who this might be right for
Hepatitis B, Chronic
Janssen Research & Development, LLC 11
Testing effectiveness (Phase 2)UnknownNCT04633902
What this trial is testing

Phase II Study of Olaparib and Pembrolizumab in Advanced Melanoma With Homologous Recombination (HR) Mutation

Who this might be right for
Metastatic Melanoma
California Pacific Medical Center Research Institute 41
Testing effectiveness (Phase 2)Study completedNCT04220307
What this trial is testing

A PD-1/CTLA-4 Bispecific Antibody AK104 in Patients With Metastatic Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Akeso 34
Testing effectiveness (Phase 2)Looking for participantsNCT06840665
What this trial is testing

MR-guided Adaptive Radiotherapy Combined With PD-1 Antibody and CAPOX for Locally Advanced Rectal Cancer

Who this might be right for
Locally Advanced Rectal Cancer
Fudan University 46
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07466303
What this trial is testing

Serplulimab Combined With Trastuzumab Rezetecan as Neoadjuvant Therapy for Triple-Negative Breast Cancer

Who this might be right for
Breast CancerSerplulimab Combined With SHR-A1811 as Neoadjuvant Therapy for Triple-Negative Breast Cancer
Xijing Hospital 84
Testing effectiveness (Phase 2)Study completedNCT06884670
What this trial is testing

Assessment of Efficacy and Safety of PD-1 Monoclonal Antibody Combined With IL-2 and CapeOX in Neoadjuvant Therapy for Locally Advanced Rectal Cancer Prior to Surgery: A Prospective, Multi-center, Randomized Controlled Study

Who this might be right for
Rectal Cancer
The First Affiliated Hospital with Nanjing Medical University 130
Testing effectiveness (Phase 2)UnknownNCT05878028
What this trial is testing

L-TIL Plus Tislelizumab for PD1 Antibody Resistant aNSCLC

Who this might be right for
Non-small Cell Lung Cancer
Quanli Gao 33
Large-scale testing (Phase 3)Study completedNCT04471428
What this trial is testing

Study of Atezolizumab in Combination With Cabozantinib Versus Docetaxel in Patients With Metastatic Non-Small Cell Lung Cancer Previously Treated With an Anti-PD-L1/PD-1 Antibody and Platinum-Containing Chemotherapy

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Hoffmann-La Roche 366
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07515469
What this trial is testing

A Prospective, Single-Arm, Exploratory Study of the Safety and Efficacy of Neoadjuvant Treatment With QL1706, an Anti-PD-1/Anti-CTLA-4 Bispecific Antibody, in Resectable Stage IB and IIA Hepatocellular Carcinoma With High Recurrence Risk

Who this might be right for
HCC - Hepatocellular CarcinomaIparomlimab and Tuvonralimab InjectionNeoadjuvant Immunotherapy
Tianjin Medical University Cancer Institute and Hospital 30
Large-scale testing (Phase 3)Looking for participantsNCT06794086
What this trial is testing

SBRT + PD-1 Monoclonal Antibody in Unresectable Colorectal Liver Metastases

Who this might be right for
Colorectal CancerLiver Metastases
Jun Huang 24
Not applicableUnknownNCT06061445
What this trial is testing

Radiotherapy Combined With TKI and Anti-PD-1 Antibody for Stage IIIA Hepatocellular Carcinoma

Who this might be right for
Stage IIIA Hepatocellular Carcinoma
Fujian Cancer Hospital 22
Early research (Phase 1)Ended earlyNCT02408861
What this trial is testing

Nivolumab and Ipilimumab in Treating Patients With HIV Associated Relapsed or Refractory Classical Hodgkin Lymphoma or Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery

Who this might be right for
Advanced Malignant Solid NeoplasmAnal CarcinomaHIV Infection+7 more
National Cancer Institute (NCI) 79
Post-approval studies (Phase 4)Looking for participantsNCT06930573
What this trial is testing

AK112, a PD-1/ VEGF Bispecific Antibody, for Resectable Hepatocellular Carcinoma With High Recurrence Risk

Who this might be right for
HCC
The First Affiliated Hospital of Zhengzhou University 30
Testing effectiveness (Phase 2)UnknownNCT01952769
What this trial is testing

Anti PD1 Antibody in Diffuse Intrinsic Pontine Glioma

Who this might be right for
DIPG
Hadassah Medical Organization 50
Not applicableLooking for participantsNCT04643041
What this trial is testing

Watch and Wait in PD-1 Monoclonal Antibody Treated dMMR/MSI-H Distal Rectal Cancer

Who this might be right for
Rectal Cancer
Sixth Affiliated Hospital, Sun Yat-sen University 47
Large-scale testing (Phase 3)Ended earlyNCT04709380
What this trial is testing

Phase III RCT of Radiotherapy Plus Toripalimab Versus Sorafenib in Advanced Hepatocellular Carcinoma With PVTT

Who this might be right for
RadiotherapyToripalimabSorafenib+1 more
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 36
Next Page